Clicky

Somnomed Limited  (SOM)

Description: SomnoMed Limited is engaged in the business of producing and selling devices for the oral treatment of sleep related disorders primarily in the Asia Pacific region, North America and Europe. The Company's products include SomnoDent Fusion, SomnoDent Flex, SomnoDent Classic, Somnodent SUAD, Somnodent SUAD Ultra, SomnoDent Herbst Advance, SomnoDent AIR & AIR+ and Morning Repositioner. The SomnoDent Herbst Advance is an intraoral device featuring a visual calibration indicator for the treatment of obstructive sleep apnea (OSA). The Company manufactures custom fit acrylic occlusal splints (dental guards), the SomnoBrux, to protect patient's teeth against heaving grinding and bruxism. Its SomnoBrux products include Gelb, Tanner and Michigan. It offers SOMGauge, which is an autoclavable instrument that can be used to construct reliable bite records. The Company provides medical reimbursement services to assist dental offices with submitting a medical claim for their patients' OSA treatment.


Keywords: Medicine Herbs Disorders Sports Equipment Sleep Disorders Grinding Sleep Sleep Apnea Physiology Obstructive Sleep Apnea Mg Mouthguard

Home Page: somnomed.com/au/

SOM Technical Analysis

20 Clarke Street
Crows Nest, NSW 2065
Australia
Phone: 61 2 9467 0400


Officers

Name Title
Mr. Neil Verdal-Austin B.Com., C.A. Global CEO, MD & Director
Mr. Hervé Fiévet Global Chief Financial Officer
Mr. Mark Harding VP of Global Marketing
Mr. Matthew Conlon Exec. VP Sales & Marketing - North America
Mr. Marco Van Kleef VP of Marketing & Sales - Europe
Dr. Jagdeep Bijwadia Chief Medical Officer
Mr. Terence A. Flitcroft B.Com., B.Comm., C.A., CA, SF FIN Company Sec.
Dr. Peter Spencer MBA Ph.D., MAICD Gen. Mang. of Operations
Mr. Christopher Bedford VP of Global Production and Product Devel.

Exchange: AU

Country: AU : Australia

Currency: Australian Dollar (A$)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 3.4915
Price-to-Sales TTM: 1.3368
IPO Date:
Fiscal Year End: June
Full Time Employees: 0
Back to stocks